Show simple item record

dc.contributor.editorJamrozik, Euzebiusz
dc.contributor.editorSelgelid, Michael
dc.date.issued2020
dc.date.submitted2020-11-13T13:34:54Z
dc.identifierONIX_20201113_9783030278748_19
dc.identifierhttps://library.oapen.org/handle/20.500.12657/42913
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/36821
dc.description.abstractThis Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century.
dc.languageEnglish
dc.relation.ispartofseriesPublic Health Ethics Analysis
dc.rightsopen access
dc.subject.otherBioethics
dc.subject.otherDrug Resistance
dc.subject.otherInfectious Diseases
dc.subject.otherMoral Philosophy and Applied Ethics
dc.subject.otherMedical Microbiology
dc.subject.otherInternal Medicine
dc.subject.otherantimicrobial resistance
dc.subject.otherpublic health ethics
dc.subject.othercollective responsibility
dc.subject.otherinfectious disease
dc.subject.otherglobal health
dc.subject.otherhospital acquired infection
dc.subject.otheranimal ethics
dc.subject.otheranimal epidemiology
dc.subject.otherTB resistance and human rights
dc.subject.otherTB resistance in developing countries
dc.subject.otherprivacy and data collection
dc.subject.otherethics and AMR regulation
dc.subject.otherethics of drug development
dc.subject.otherPharmacology
dc.subject.otherInfectious & contagious diseases
dc.subject.otherthema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSA Life sciences: general issues::PSAD Bioethics
dc.subject.otherthema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
dc.subject.otherthema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCJ Infectious and contagious diseases
dc.titleEthics and Drug Resistance: Collective Responsibility for Global Public Health
dc.typebook
oapen.identifier.doi10.1007/978-3-030-27874-8
oapen.relation.isPublishedBy9fa3421d-f917-4153-b9ab-fc337c396b5a
oapen.relation.hasChapterChapter 9 Moral Responsibility and the Justification of Policies to Preserve Antimicrobial Effectiveness
oapen.relation.hasChapter445506a0-08ae-4042-88c1-6da2e8d80afc
oapen.relation.hasChapter2b940e2e-21a5-4b3d-b73a-9e1252fbee34
oapen.imprintSpringer International Publishing
oapen.pages448
dc.seriesnumber5


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Chapters in this book

open access
Except where otherwise noted, this item's license is described as open access